Atlas Trials

Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging

Clinical trial NCT03568448 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03568448
Sponsor
New Mexico Cancer Research Alliance
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
HER2 Negative Breast Cancer
Start date
2018-04-16
Primary completion
2020-01-22
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.